Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find Clinical Trials & Studies

AMETHYST – Lupus Study

I'm Interested!

A 2-Part Seamless Part A (Phase 2)/Part B (Phase 3) Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BIIB059 in Participants with Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cutaneous Lupus Erythematosus with or without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy (AMETHYST)

  • Sex: Any
  • Age: Adult (18 - 64), Older Adult (65+)
  • Accepting Healthy People: No
  • Type: Interventional / Therapeutic
  • Trial Phase: Phase II/III
  • Conditions Being Studied:

Study Purpose

The purpose of this study is to evaluate if the investigational study drug, BIIB059, can reduce disease activity and inflammation in people with active CLE compared to a placebo.

Who Can Participate

Participants 18 years and older who has been diagnosed with an autoimmune disease known as cutaneous lupus erythematosus may be eligible for this study.

Principal Investigator
Neil Korman MD PhD
Department/Division
Dermatology (Allergy Immunology)
  • UH IRB: SITE00001693
  • StudyID: 2022-0872
  • ClinicalTrials.gov: NCT05531565
I'm Interested!

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422